I agree. I think, too, probably one of the more prominent conclusions today, and I think you made the case well, is the role of the long-range strike forces in irregular warfare, larger than most people would intuitively think.

The fight we're in is irregular, it's a hybrid, we can't do everything.

These investments in systems like the F-22, in my view, are investments in deterrents.

My basic feeling is that this country, because of its global responsibilities, does need a credible capability to hold targets at risk anywhere on the globe.

It's been a very helpful hearing, from the subcommittee's point of view.

I appreciate it, and we'll have some good questions for you.

That's what, in our world, we tend to call straight talk.

I think we're looking further downstream into the future, at emerging threats.

I think you framed the questions very well.

I would look forward to working with you to make sure that the balance between our law enforcement needs and our border security needs are appropriately weighed against the relevant privacy interests.

Luck comes to those who work hard for it.

As Senator Bingaman said in introducing you, you have served in a number of positions directly relevant to national preparedness.

I hope, as you begin your review, that when you see areas particularly related to cyber security where you think the Department needs additional statutory authority, you will feel comfortable in working with the Committee on that.

I want to thank you, Mr. Manning, as we consider your nomination to be Deputy Administrator for FEMA in charge of National Preparedness.

I hope to do the same with you.

Let me ask you to bring all that and all your experience to bear on the current H1N1 flu crisis.

I think the quality of the nominees has really been very high, and that is certainly true of these two.

I congratulate your parents on producing such an admirable son.

Physicians treating critically ill patients with H1N1 influenza will soon have access to new antiviral drugs supported by HHS/BARDA and administered intravenously under a CDC-sponsored Emergency Use Authorization.

At no time in our Nation's history have we been better prepared to deal with exactly this kind of crisis.

the vaccines are working, of course.

I was surprised, 22 million illnesses, 98,000 hospitalizations, more than 3,900 deaths, including, as we said, about 540 children.

I want to say frankly to you this morning that I am concerned, as we meet this morning, that the flu is spreading so rapidly and in some cases with such intensity that it may well be getting ahead of the Federal Government's ability and…

the more people who go back and forth between Mexico and here, isn't it more likely that there will be more contagion occurring?

I want to thank the three of you for your testimony this morning and go back to the beginning and thank you for the work that you have done since this H1N1 virus appeared and broke out in April of this year.